Tafasitamab and lenalidomide in large B cell lymphoma: real-world outcomes in a multicenter retrospective study. Qualls DA, Lambert N, Caimi PF, Merrill MH, et al. Blood 2023 Sep 22:blood.2023021274. doi: 10.1182/blood.2023021274.

Read + Share

Amedeo Smart

Independent Medical Education

Qualls DA, Lambert N, Caimi PF, Merrill MH, et al. Tafasitamab and lenalidomide in large B cell lymphoma: real-world outcomes in a multicenter retrospective study. Blood 2023 Sep 22:blood.2023021274. doi: 10.1182/blood.2023021274.
PMID: 37738563